Curant Rare Partners as Exclusive Pharmacy for FDA-Approved Neuroblastoma Drug IWILFIN™

Curant Rare Becomes Exclusive Pharmacy Partner for IWILFIN™, Transforming Access and Care for High-Risk Neuroblastoma Patients Curant Health has announced a major milestone in oncology care through its specialty division, Curant Rare, which is now the exclusive pharmacy partner for…










